New pill could regrow hair in balding men
NCT ID NCT06972264
First seen Nov 06, 2025 · Last updated May 07, 2026 · Updated 28 times
Summary
This study tests an experimental oral drug called VDPHL01 for male pattern baldness (androgenetic alopecia). About 480 men aged 18 to 65 with mild to moderate hair loss will take the drug or a placebo daily for about 13 months. The main goal is to see if the drug increases hair count and if participants notice a benefit after 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANDROGENETIC ALOPECIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Site 51
Austin, Texas, 78759, United States
-
Site 52
Louisville, Kentucky, 40241, United States
-
Site 53
Clarksville, Indiana, 47129, United States
-
Site 54
Ocala, Florida, 34470, United States
-
Site 55
Plainfield, Indiana, 46168, United States
-
Site 57
Portland, Oregon, 97210, United States
-
Site 59
Quincy, Massachusetts, 02169, United States
-
Site 60
Anderson, South Carolina, 29625, United States
-
Site 61
Chicago, Illinois, 60611, United States
-
Site 62
Coral Gables, Florida, 33146, United States
-
Site 63
Norfolk, Virginia, 23502, United States
-
Site 64
Manhattan Beach, California, 90266, United States
-
Site 66
Santa Monica, California, 90404, United States
-
Site 67
Dallas, Texas, 75230, United States
-
Site 68
Clinton Township, Michigan, 48038, United States
-
Site 69
Encino, California, 91436, United States
-
Site 70
Mill Creek, Washington, 98012, United States
-
Site 71
Boca Raton, Florida, 33486, United States
-
Site 72
Cincinnati, Ohio, 45236, United States
-
Site 73
Birmingham, Alabama, 35209, United States
-
Site 74
College Station, Texas, 77845, United States
-
Site 75
New Orleans, Louisiana, 70124, United States
-
Site 76
Austin, Texas, 78746, United States
-
Site 77
Phoenix, Arizona, 85006, United States
-
Site 78
Plano, Texas, 75024, United States
-
Site 79
Leawood, Kansas, 66211, United States
-
Site 80
Chestnut Hill, Massachusetts, 02467, United States
-
Site 81
East Greenwich, Rhode Island, 02818, United States
-
Site 82
Hickory, North Carolina, 28602, United States
-
Site 83
Troy, Michigan, 48084, United States
-
Site 84
Glenn Dale, Maryland, 20769, United States
-
Site 85
Norfolk, Virginia, 23502, United States
-
Site 86
Coral Gables, Florida, 33134, United States
-
Site 87
Rockville, Maryland, 20850, United States
-
Site 88
San Antonio, Texas, 78218, United States
-
Site 89
Birmingham, Alabama, 35244, United States
-
Site 90
Sandy Springs, Georgia, 30328, United States
-
Site 91
Sugarland, Texas, 77479, United States
-
Site 92
Huntersville, North Carolina, 28078, United States
-
Site 93
Northridge, California, 91324, United States
-
Site 94
Thousand Oaks, California, 91320, United States
-
Site 95
Hermitage, Tennessee, 37076, United States
-
Site 96
Tamarac, Florida, 33321, United States
-
Site 99
Miami, Florida, 33173, United States
Conditions
Explore the condition pages connected to this study.